Brandon Smith — 510(k) & De Novo Consultant (General Surgery/Gastro Urology)
Surgeon-Scientist
MD/PhD Surgeon-Scientist with extensive operative experience in general, oncologic, minimally invasive, and robotic surgery. Holds a PhD in Tissue Engineering, providing unique expertise in biomaterials and implantable devices. Dr. Smith advises MedTech companies and investors on clinical feasibility, surgeon adoption, and OR workflow integration for new surgical technologies. He bridges the gap b...
Experience: 7+ years
Expertise & Specializations
Regulatory Pathways
Device Specialties
Regions Served
Brandon Smith provides regulatory consulting services to clients in:
Credentials & Recognition
Education & Credentials
This consultant possesses a distinguished educational background, holding both a Doctor of Medicine (MD) from Baylor College of Medicine and a PhD in Tissue Engineering & Biomaterials from Rice University. This powerful MD/PhD combination, obtained from top-tier institutions, provides a rare and valuable perspective that bridges clinical practice with deep material science. For medtech companies, this dual expertise is critical for evaluating the clinical feasibility of novel biomaterials and implantable devices, ensuring that regulatory strategies are grounded in both scientific validity and real-world surgical application.
As a published researcher, this consultant has contributed to numerous peer-reviewed publications in prestigious scientific fields. Their research and publications cover topics essential to MedTech innovation, including tissue engineering, biomaterial performance, advanced wound care, and the evaluation of robotic surgical techniques. This body of work establishes them as a credible thought leader whose scientific and clinical insights are validated by the academic community, adding significant weight to regulatory and clinical strategy discussions.
Professional Experience
As a surgeon-scientist, this consultant has built a career at the intersection of clinical surgery and MedTech innovation. Their experience is defined by providing high-level strategic advice to investors and medical device companies on the viability of new surgical technologies. They possess deep operative experience across a wide range of surgical disciplines, including oncology, minimally invasive, and robotic surgery. This hands-on clinical practice enables them to offer unparalleled insights into surgeon adoption behaviors, OR workflow integration, and real-world device performance, which are crucial factors for successful commercialization and regulatory approval. Their work focuses on translating bench-stage concepts into clinically successful products by identifying and mitigating adoption barriers early in the development process.
Executive Summary
Professional Overview
MD/PhD Surgeon-Scientist with extensive operative experience in general, oncologic, minimally invasive, and robotic surgery. Holds a PhD in Tissue Engineering, providing unique expertise in biomaterials and implantable devices. Dr. Smith advises MedTech companies and investors on clinical feasibilit...
Core Specializations
Regulatory Pathways
Device Specialties
Services Offered
Quality management system development, gap analysis, and ISO 13485 certification support for medical device manufacturers.
Risk management system development, risk analysis, and ISO 14971 compliance support for medical device risk management.
Strategic assessment to determine the appropriate FDA regulatory pathway (510(k), De Novo, PMA) for your medical device.
Strategic planning and support for De Novo and PMA pathways, including clinical trial design and FDA meeting preparation.
Post-market surveillance, adverse event reporting, and ongoing regulatory compliance support.
Cruxi Independent Snapshot
Best suited for
- • MedTech companies seeking expert regulatory guidance
Experience signals
- Regions: US
- Background: 7+ years of regulatory experience.
Cruxi view
Brandon Smith provides an exceptionally rare perspective as an active MD/PhD Surgeon-Scientist with 7 years of specialized experience advising MedTech innovators. His unique value stems from combining extensive, hands-on operative experience in robotics and minimally invasive surgery with a PhD in Tissue Engineering, making him a premier expert for companies developing implantable devices and advanced surgical systems. His expertise is crucial for shaping early-stage regulatory strategy for complex De Novo, PMA, and IDE pathways by providing deep clinical feasibility analysis and surgeon adoption insights. For medtech companies, Dr. Smith is the critical strategic partner who translates clinical needs into a defensible regulatory and commercialization plan, significantly de-risking novel technology development.
This analysis is generated by Cruxi AI using public information and may not capture the full scope of the consultant's experience.
Contact Brandon Smith
Share a brief overview of your device and timeline. Cruxi will forward your request to Brandon Smith and help structure next steps.
Contact Now